HuGE Literature Finder
Records
1
-
30
| Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance. Gynecologic oncology 2022 Jan . Kashofer Karl, Regauer Sigrid, Reich Olaf, Petru Edgar, Winter El |
| Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer. Breast (Edinburgh, Scotland) 2022 Jan 62 52-60. Lee Soohyeon, Park Kyunghee, Kim Gun Min, Jung Kyung Hae, Kang Seok Yun, Park In Hae, Kim Jee Hyun, Ahn Hee Kyung, Park Woong-Yang, Im Seock-Ah, Park Yeon H |
| Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinoma. Pathology, research and practice 2022 Jan 231 153761. Chen Ying, Kong Wencui, Yu Zongyang, Zhao Zhongqu |
| Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population. Annals of medicine 2021 Dec 53 (1): 1358-1369. Wang Liye, Zhai Qinglian, Lu Qianyi, Lee Kaping, Zheng Qiufan, Hong Ruoxi, Wang Shus |
| Alterations in the RB Pathway With Inactivation of RB1 Characterize Glioblastomas With a Primitive Neuronal Component. Journal of neuropathology and experimental neurology 2021 Nov . Chkheidze Rati, Raisanen Jack, Gagan Jeffrey, Richardson Timothy E, Pinho Marco C, Raj Karuna, Achilleos Michael, Slepicka Chenelle, White Charles L, Evers Bret M, Patel Toral R, Malter James S, Hatanpaa Kimmo |
| Clinical and genomic features of SPOP-mutant prostate cancer. The Prostate 2021 Nov . Nakazawa Mari, Fang Mike, H Marshall Catherine, Lotan Tamara L, Isaacsson Velho Pedro, Antonarakis Emmanuel |
| Identification of novel RB1 genetic variants in Retinoblastoma patients and their impact on clinical outcome. Ophthalmic genetics 2021 Oct 1-9. Manukonda Radhika, Pujar Akhilesh, Ramappa George, Vemuganti Geeta K, Kaliki Swat |
| Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Deletion Lung Cancer. Clinical lung cancer 2021 Oct . Hellyer Jessica A, White Maya N, Gardner Rebecca M, Cunanan Kristen, Padda Sukhmani K, Das Millie, Ramchandran Kavitha, Neal Joel W, Wakelee Heather |
| The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-related cancer 2021 Oct . Venizelos Andreas, Elvebakken Hege, Perren Aurel, Nikolaienko Oleksii, Deng Wei, Lothe Inger Marie B, Couvelard Anne, Hjortland Geir Olav, Sundlöv Anna, Svensson Johanna B, Garresori Harrish, Kersten Christian, Hofsli Eva, Detlefsen Sonke, Krogh Merete, Sorbye Halfdan, Knappskog Sti |
| PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort. Clinical lung cancer 2021 Aug . Jin Yan, Xue Qianqian, Shen Xuxia, Zheng Qiang, Chen Haiquan, Zhou Xiaoyan, Li Yu |
| Two progressed malignant phyllodes tumors of the breast harbor alterations in genes frequently involved in other advanced cancers. Orphanet journal of rare diseases 2021 Aug 16 (1): 363. Reinisch Mattea, Kuemmel Sherko, Breit Elisabeth, Theuerkauf Ingo, Harrach Hakima, Schindowski Dorothea, Moka Detlef, Bettstetter Marcus, Bruzas Simona, Chiari Ouaf |
| AR gene rearrangement analysis in liquid biopsies reveals heterogeneity in lethal prostate cancer. Endocrine-related cancer 2021 Jul . Daniel Mark, Knutson Todd P, Sperger Jamie M, Li Yingming, Singh Anupama, Stahlfeld Charlotte N, Passow Courtney, Auch Benjamin, Lang Joshua M, Dehm Scott |
| Dynamics of circulating tumor DNA during postoperative radiotherapy in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: a prospective observational study. Breast cancer research and treatment 2021 Jun . Kim Haeyoung, Kim Yeon Jeong, Park Donghyun, Park Woong-Yang, Choi Doo Ho, Park Won, Cho Won Kyung, Kim Nal |
| Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients. Cancer chemotherapy and pharmacology 2021 Jun . Sokolenko Anna P, Gorodnova Tatiana V, Bizin Ilya V, Kuligina Ekaterina Sh, Kotiv Khristina B, Romanko Alexandr A, Ermachenkova Tatiana I, Ivantsov Alexandr O, Preobrazhenskaya Elena V, Sokolova Tatiana N, Broyde Robert V, Imyanitov Evgeny |
| Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients. Hepatobiliary surgery and nutrition 2021 Apr 10 (2): 172-179. Wang Shuo, Shi Huasheng, Liu Tao, Li Manjiang, Zhou Sanshun, Qiu Xuan, Wang Zusen, Hu Weiyu, Guo Weidong, Chen Xiaoqian, Guo Honglin, Shi Xiaoliang, Shi Junping, Zang Yunjin, Cao Jingyu, Wu Liq |
| RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer. BMC cancer 2021 Apr 21 (1): 432. Manzano Ramon Gonzalez, Catalan-Latorre Ana, Brugarolas Anton |
| The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients. International journal of cancer 2021 Apr . Cai Lei, Chen Yong, Tong Xiaoling, Wu Xue, Bao Hua, Shao Yang, Luo Zhuang, Wang Xuming, Cao Ya |
| Comprehensive analysis of mutational and clinicopathologic characteristics of poorly differentiated colorectal neuroendocrine carcinomas. Scientific reports 2021 Mar 11 (1): 6203. Lee Sun Mi, Sung Chang O |
| Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study. Lung cancer (Amsterdam, Netherlands) 2021 Mar 155 20-27. Wang Wenxian, Xu Chunwei, Chen Huafei, Jia Jinhao, Wang Liping, Feng Huijing, Wang Hong, Song Zhengbo, Yang Nong, Zhang Yongcha |
| Plasma tumor gene conversions after one cycle abiraterone acetate for metastatic castration-resistant prostate cancer: a biomarker analysis of a multicenter international trial. Annals of oncology : official journal of the European Society for Medical Oncology 2021 Mar . Jayaram A, Wingate A, Wetterskog D, Wheeler G, Sternberg C N, Jones R, Berruti A, Lefresne F, Lahaye M, Thomas S, Gormley M, Meacham F, Garg K, Lim L P, Merseburger A S, Tombal B, Ricci D, Attard |
| Comprehensive genomic profiling of combined small cell lung cancer. Translational lung cancer research 2021 Feb 10 (2): 636-650. Zhang Jing, Zhang Liping, Luo Jie, Ge Tao, Fan Pengyu, Sun Liangdong, Hou Likun, Li Junqiang, Yu Huansha, Wu Chunxiao, Zhu Yuming, Wu Chunyan, Jiang Gening, Troncone Giancarlo, Malhotra Jyoti, Okuda Katsuhiro, Santarpia Mariacarmela, Zamarchi Rita, Goto Taichiro, Cardona Andrés F, Xu Jianfang, Chen Qiankun, Zhang Zhonghong, Zhang Peng, |
| Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder. Signal transduction and targeted therapy 2021 Feb 6 (1): 55. Liu Fatao, Li Yongsheng, Ying Dongjian, Qiu Shimei, He Yong, Li Maolan, Liu Yun, Zhang Yijian, Zhu Qin, Hu Yunping, Liu Liguo, Li Guoqiang, Pan Weihua, Jin Wei, Mu Jiasheng, Cao Yang, Liu Yingb |
| Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusions. Prostate cancer and prostatic diseases 2021 Jan . Chalmers Zachary R, Burns Michael C, Ebot Ericka M, Frampton Garrett M, Ross Jeffrey S, Hussain Maha H A, Abdulkadir Sarki |
| Mutation profile of non-small cell lung cancer revealed by next generation sequencing. Respiratory research 2021 Jan 22 (1): 3. Chang Ya-Sian, Tu Siang-Jyun, Chen Yu-Chia, Liu Ting-Yuan, Lee Ya-Ting, Yen Ju-Chen, Fang Hsin-Yuan, Chang Jan-Gow |
| Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma. Frontiers in oncology 2021 11 653153. Saghaeiannejad Esfahani Hoda, Vela Cory M, Chauhan Am |
| Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China. Frontiers in oncology 2021 11 630717. Lv Weize, Cheng Hua, Shao Di, Wei Yajun, Zhu Weiping, Wu Kui, Jiang Wenxi, Hu Liyang, Sha Zhou, Zhong Beilong, Pei Xiaofe |
| Predictive and Prognostic Potential of TP53 in Patients With Advanced Non-Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial (CTONG 0901). Clinical lung cancer 2020 Nov . Li Xiang-Meng, Li Wen-Feng, Lin Jun-Tao, Yan Hong-Hong, Tu Hai-Yan, Chen Hua-Jun, Wang Bin-Chao, Wang Zhen, Zhou Qing, Zhang Xu-Chao, Su Jian, Chen Rui-Lian, Wu Yi-Long, Yang Jin- |
| Genetic and clinical landscape of breast cancers with germline BRCA1/2 variants. Communications biology 2020 Oct 3 (1): 578. Inagaki-Kawata Yukiko, Yoshida Kenichi, Kawaguchi-Sakita Nobuko, Kawashima Masahiro, Nishimura Tomomi, Senda Noriko, Shiozawa Yusuke, Takeuchi Yasuhide, Inoue Yoshikage, Sato-Otsubo Aiko, Fujii Yoichi, Nannya Yasuhito, Suzuki Eiji, Takada Masahiro, Tanaka Hiroko, Shiraishi Yuichi, Chiba Kenichi, Kataoka Yuki, Torii Masae, Yoshibayashi Hiroshi, Yamagami Kazuhiko, Okamura Ryuji, Moriguchi Yoshio, Kato Hironori, Tsuyuki Shigeru, Yamauchi Akira, Suwa Hirofumi, Inamoto Takashi, Miyano Satoru, Ogawa Seishi, Toi Masaka |
| Specific Gene Co-variation Acts Better Than Number of Concomitant Altered Genes in Predicting EGFR-TKI Efficacy in Non-small-cell Lung Cancer. Clinical lung cancer 2020 Sep . Zhu Yan-Juan, Qu Xin, Zhan Dan-Dan, Chen Hui-Hui, Li Hai-Peng, Liu Li-Rong, Chen Xian, Liu Yi-Hong, Li Yong, Bai Jian-Ping, Ye Sheng, Zhang Hai- |
| Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer. Journal of oncology 2020 2020 8811487. Chen Dongfang, Xu Jianlin, Qiao Rong, Zhao Yizhuo, Chu Tianqing, Han Baohui, Zhong Run |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 26, 2022
- Content source: